Coronary artery disease (CAD) treatment startup SpectraWave announced today that it has appointed Eman Namati as its new CEO.
Bedford, Mass.-based SpectraWave is developing a medical imaging platform that uses photonics to improve CAD outcomes.
Namati joins with more than a decade of experience leading the development and launch of highly technical medical imaging products, according to a news release. He was previously CEO of NinePoint Medical.
“The board, founders, and team at SpectraWave have been an inspiring group to join,” Namati said in the release. “They are talented, experienced, and purpose-driven, which will be key as we move towards the launch of our new photonic imaging technology for coronary artery disease. Our flagship technology will define our clinical impact and growth, and we are working hard to bring that solution to the market to help as many patients as possible with coronary artery disease.”
“Eman’s experience aligns perfectly with SpectraWave’s product and mission and we’re excited he is leading our team” added SpectraWave board chair Steve Weinstein. “The development of a novel cardiac imaging product requires collaboration across technical disciplines within a highly regulated product development process. Eman not only brings strong leadership and technical success, but also commercialization experience that positions the company well for future growth.”